These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2807324)

  • 1. Comments on "Analytical Solution to the Three-Compartment Pharmacokinetic Model".
    Larsen JL; Arzbaecher R
    IEEE Trans Biomed Eng; 1989 Nov; 36(11):1141-2. PubMed ID: 2807324
    [No Abstract]   [Full Text] [Related]  

  • 2. Analytical solution to the three-compartment pharmacokinetic model.
    Jacobs JR
    IEEE Trans Biomed Eng; 1988 Sep; 35(9):763-5. PubMed ID: 3272130
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo simulation of human pharmacokinetics in the rabbit.
    Bugnon D; Potel G; Caillon J; Baron D; Drugeon HB; Feigel P; Kergueris MF
    Bull Math Biol; 1998 May; 60(3):545-67. PubMed ID: 9608855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum experimental designs for properties of a compartmental model.
    Atkinson AC; Chaloner K; Herzberg AM; Juritz J
    Biometrics; 1993 Jun; 49(2):325-37. PubMed ID: 8369370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the theory of the optimal sampling scheme for bioequivalence studies].
    Tod M; Petitjean O; Nicolas P
    Therapie; 1993; 48(1):7-13. PubMed ID: 8356559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of direct search optimization for pharmacokinetic parameter estimation.
    Khorasheh F; Sattari S; Gerayeli A; Ahmadi AM
    J Pharm Pharm Sci; 1999; 2(3):92-8. PubMed ID: 10953255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hybrid model: a new pharmacokinetic model for computer-controlled infusion pumps.
    Wada DR; Ward DS
    IEEE Trans Biomed Eng; 1994 Feb; 41(2):134-42. PubMed ID: 8026846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel.
    Dansirikul C; Choi M; Duffull SB
    Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition and determination of important pharmacokinetic parameters for dosage regimen (one compartment model).
    Seydel JK
    Eur J Toxicol Hyg Environ; 1972; 5(5 Suppl):53-61. PubMed ID: 14732951
    [No Abstract]   [Full Text] [Related]  

  • 10. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2006 Sep; 203(1):19-36. PubMed ID: 16616213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical study of three-compartment pharmacokinetic models: concentration, area under curves, mean residence time.
    Plusquellec Y
    J Biomed Eng; 1989 Jul; 11(4):345-51. PubMed ID: 2619796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
    van den Bongard HJ; Mathôt RA; van Tellingen O; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data.
    Ramanathan M
    Drug Metab Dispos; 1999 Dec; 27(12):1479-87. PubMed ID: 10570030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.
    Wajima T; Yano Y; Oguma T
    J Pharm Pharmacol; 2002 Jul; 54(7):929-34. PubMed ID: 12162711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of age on the pharmacokinetic parameters of digoxin].
    Korkushko OV; Orlov PA; Bezverkhaia IS; Belyĭ AA
    Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can we use a Bayesian method to build a pharmacokinetic population in two steps?].
    Cabelguenne D; Bleyzac N; Pivot C; Maire P
    Therapie; 2000; 55(2):277-82. PubMed ID: 10967700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curvature-adjusted optimal design of sampling times for the inference of pharmacokinetic compartment models.
    Daimon T; Goto M
    Stat Med; 2007 Jun; 26(14):2799-812. PubMed ID: 17072822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic features in forensic medicine.
    Wehner HD
    Forensic Sci Int; 2007 Jan; 165(2-3):225-32. PubMed ID: 16814502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.